Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouMost GCC skincare sourcing problems do not start in the factory — they start in the contract. A brand owner signs a manufacturing agreement, assumes the manufacturer will "handle registration," and discovers six weeks…
Most GCC skincare sourcing problems do not start in the factory — they start in the contract. A brand owner signs a manufacturing agreement, assumes the manufacturer will “handle registration,” and discovers six weeks before launch that no one actually owns the local product notification, the Arabic label sign-off, or the import permit. This guide maps exactly where the responsibility line should sit for UAE, Saudi Arabia, and other GCC markets, and what documents you should require before you sign.
The Gulf Cooperation Council is a customs and standards harmonization bloc, not a single regulatory authority. Cosmetic products are governed by a GCC technical regulation (GSO 1943:2024 for cosmetics), but market access is granted nationally. That means:
Two consequences follow directly from this structure, and both belong in your contract:
For skincare specifically, the regulatory conversation is further shaped by the product itself: preservative systems, actives, pH, and claims such as “anti-acne,” “whitening,” or “repairs the skin barrier” can move a product out of the ordinary cosmetic route and into a higher-scrutiny category. That classification decision must be made before the label is designed, because it determines which registration documents you need at all.
The cleanest way to allocate responsibility is to separate three things that are often lumped together as “registration”:
A manufacturer that promises all three is either overstating its capability or quietly subcontracting to a local agent whose name is not in your contract. Either way, you lose visibility.
| Workstream / document | Manufacturer delivers | Local party must own | Evidence to request |
|---|---|---|---|
| Formula and full INCI declaration | Version-controlled formula, INCI listing aligned to destination nomenclature, ingredient percentages on request | Confirms cosmetic vs. higher-risk classification and permitted claims | Signed formula sheet with version number and date, linked to the batch record |
| Fragrance documentation | IFRA certificate and allergen declaration for the fragrance concentrate used | Confirms fragrance and allergen levels meet destination limits | Current IFRA certificate plus allergen breakdown matching the exact formula version |
| Batch quality documents | Certificate of Analysis and Safety Data Sheet | Verifies the imported batch matches the registered formula | Batch-specific COA, SDS with revision date and language version |
| Stability, microbiological and packaging compatibility | Accelerated and real-time stability, preservative efficacy, high-temperature and pack compatibility reports | Accepts or rejects shipping, warehouse and retail storage conditions | Test protocol plus raw data, including elevated-temperature results and a compatibility report naming the exact pack components |
| Manufacturing credentials | GMP certificate, manufacturing licence, Free Sale or Certificate of Manufacture | Verifies authenticity with the issuing body and confirms scope covers the product type | Certificates with issuing authority, validity dates and product scope visible |
| Artwork and bilingual labeling | Technical label content: INCI, warnings, batch coding, PAO, net content | Final label approval against local language and format requirements, including Arabic | Approved artwork proof plus a written label sign-off record dated before print |
| Product notification / registration | Technical dossier inputs on request, in the format the local submitter needs | Submits the notification, pays fees, and holds the registration in its name | Notification or registration number, named holder, and the exact market it covers |
| Import and market release | Shipping documentation and technical support for customs queries | Import permit, customs clearance, release to trade | Import permit number and clearance record tied to the shipment |
| Post-market surveillance | Batch traceability, complaint data, reformulation notifications | Adverse event handling, recall execution, regulator communication | Traceability map from batch code to shipment, plus a written adverse event procedure |
Two entries in that table cause the most disputes in practice. The first is registration holder name: if the notification sits with a distributor rather than your appointed local entity, changing distributors later can strand your registration. The second is label approval: manufacturers routinely print artwork that a local authority later rejects because Arabic content, allergen naming, or warning statements were not reviewed by someone accountable for that market.
Vague cooperation language (“Supplier will assist with regulatory documentation”) is unenforceable. Replace it with defined deliverables.
Name the countries and, for the UAE, name the emirate. “GCC” is not a scope. A contract that lists “UAE (Dubai), KSA — first launch” and “additional GCC markets by written amendment” prevents the assumption that a Dubai registration covers Riyadh.
Attach an annex listing every document the manufacturer will provide, the file format, the language, and the date relative to production (for example, “dossier inputs delivered no later than 10 working days after formula lock”). Tie final payment milestones to document delivery, not only to shipment.
Any change to formula, fragrance, preservative system, packaging material, or label text can invalidate a registration or a stability conclusion. The contract should state that no change is implemented without written buyer approval, and that the manufacturer will notify you of any supplier-side substitution within a defined window.
The buyer should hold the right to use the technical dossier for its own registrations, and to receive a complete, transferable copy on termination. Without this, switching manufacturers can mean restarting registration from zero.
Authorities frequently come back with questions about the formula, the safety assessment, or the manufacturing site. Define who answers, in what format, and within how many working days.
Specify the retention period for batch records and stability data, and confirm it satisfies the destination market’s requirement. Include a right to request batch records and COAs for any shipment within that period.
Whether you are launching in Dubai, Riyadh, or both, the technical core is largely the same. What changes is the submission wrapper and the label.
One warning on claims: skin-lightening and acne-treatment language is among the fastest ways to change a product’s regulatory category in GCC markets. Verify the claim, the active ingredient, and the permitted concentration with the local responsible entity before artwork is finalized — not after the first shipment is held at customs.
Registration documents and production milestones must run in parallel, not sequentially. The realistic order is: formula and claims lock → stability and compatibility testing → artwork development → local label review → notification submission → pilot or first production batch → batch-specific COA and final document handover. Compressing testing to save two weeks is the most common cause of a two-month delay downstream.
| Phase | Buyer action | Manufacturer action | Evidence output |
|---|---|---|---|
| Formula and claims lock | Confirm target markets and claim set | Issue controlled formula and INCI | Signed formula sheet, claims matrix |
| Testing | Approve test plan and pack selection | Run stability, preservative efficacy, compatibility | Test reports with raw data |
| Artwork and label review | Route artwork to local responsible entity | Supply technical label content | Approved bilingual artwork |
| Notification | Submit and hold the registration locally | Provide dossier inputs on request | Registration number and holder name |
| Production and handover | Release print and production | Manufacture, test, assemble documents | Batch COA, SDS, full document transmittal |
No. Dubai registration applies to the Dubai market under Dubai Municipality requirements. Saudi Arabia is governed by the SFDA and requires its own notification through a local responsible entity. Other emirates and other GCC states must be verified individually for each project.
Usually not directly. Registration is normally held by a locally licensed importer, distributor, or appointed responsible entity. The manufacturer’s role is to supply the technical dossier in the required format and respond to regulator queries. Confirm in writing whose name appears on the registration before you sign the manufacturing agreement.
Formula and INCI, fragrance IFRA and allergen documentation where relevant, batch COA and SDS, stability and compatibility data, microbiological and preservative efficacy results, GMP certificate, manufacturing licence, Free Sale Certificate, technical label content, and production samples.
Through a contractual change control process. Any formula, fragrance, preservative, packaging, or label change should require written buyer approval and a defined trigger for re-testing and re-notification. Without this clause, a supplier-side substitution can quietly invalidate your registration.
Treat it as a request for clarification. Compliance is demonstrated per market, with named documents and a named registration holder. Ask for the specific notification number, the holder name, and the market it covers.
Informational only. This guide is not legal or regulatory advice; confirm requirements for each destination market with your local responsible entity or qualified counsel.
Next step: If you are scoping a GCC skincare launch, share your target markets (UAE emirate and/or KSA), SKU count and formats, positioning, packaging direction, and timeline. That information lets us return a quotation with a document pack scope mapped to each market rather than a generic price list. Request a Quote.